Pleiotropy HDWAS

HDWAS Prescribing in Taiwan graph info

Insight

Phasing out of Allopurinol for gout 痛風 in Taiwan

2025 03 19 Owen Yang

A BMJ report in 2015 confirmed that near 20% of Taiwanese carry HLA-B*58:01, a genetic variant associated with allopurinol-induced severe cutaneous adverse reactions (SCARs). This has caused the shifting of prescribing medication for gout from Allopurinol (#M04AA01) to Febuxostat (#M04AA03) in the 2010s.

Go to all insights

All ATC codes in this group and OTC availability

M04AA03

febuxostat

not available OTC

Graphs

Prescribing in Taiwan

M04AA03 Febuxostat (Oral)
Agents for inhibiting urine productions.

Prescribing rates

Prescribing rates

Pleiotropy Ltd Registered in England and Wales | Company No. 14050311 Registered Office: 106 Valentia Road Oxford OX3 7PW Disclaimer: Content on this site is for informational and research purposes only and is not intended as medical advice.